Pfizer Wins Another Battle In Norvasc War

Law360, New York (September 1, 2006, 12:00 AM EDT) -- Two weeks after a jury ruled unanimously in its favor, Pfizer Inc. has chalked up another victory in its crusade to protect its blockbuster blood pressure medication, Norvasc, from a generic challenge.

On Friday, the pharmaceutical giant revealed that a North Carolina federal court judge had upheld its patent covering amlodipine besylate, the active ingredient found in Norvasc.

The ruling, handed down by Judge James A. Beaty, will block Dutch generics maker Synthon Pharmaceuticals from selling a version of the drug until September 2007, the patent’s...
To view the full article, register now.